Product Information
METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.1870 per EA under NDC 68001047100. Its NADAC has been published 229 times since Jun 30, 2021.
FDA first approved this application on Oct 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the metoprolol succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001047100
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA207465FDA Approved
10/26/2018
TE Code
AB
On Market Since
8/4/2023
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 229 times since Jun 30, 2021, and over the history we have for it it has declined 54.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1870 per EA |
|---|---|
| All-time high | $0.4214 (Dec 15, 2021) |
| All-time low | $0.1284 (Nov 20, 2024) |
| 52-week high | $0.1997 |
| 52-week low | $0.1588 |
| Median price | $0.1993 |
| Average price | $0.2217 |
| Largest weekly change | -33.6% (Dec 22, 2021) |
| Weeks tracked | 229 |
| Tracking since | Jun 30, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by BluePoint Laboratories, is $0.1870 per EA (NDC 68001047100), effective Aug 19, 2026.
How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 54.5%. It has been tracked across 229 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?
Since Jun 30, 2021, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1284 (Nov 20, 2024) to a high of $0.4214 (Dec 15, 2021), with a median of $0.1993 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 200 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL SUCC ER 200 MG TAB?
METOPROLOL SUCC ER 200 MG TAB (NDC 68001047100) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.